ORALLY ADMINISTERED PRODUCT FOR PREVENTING AND TREATING GASTROINTESTINAL INFECTIONS WITH SWINE AND METHOD OF PRODUCING ANTIBODIES AGAINST PATHOGENES OF SUCH INFECTIONS

摘要

Oral product for the prevention and therapy of porcine gastrointestoinal infections containing at least one specific antibody to porcine rotavirus, porcine coronavirus, enteropathogenic and enterotoxigenic bacterial strains of Escherichia coli, Clostridium sp., Salmonella sp. and protozoan strains of Isospora sp. and Cryptosporidium sp, obtained from egg yolks of immunized hens. Further, the product contains at least one strain of live stabilized cultures of lactacidogenic bacteria. Technology of production consisting of separate submersive culture of selected individual strains of lactacidogenic bacterial species Enterococcus faecium, Lactobacillus casei and, if appropriate, Lactobacillus plantarum, followed by the separation of the bacterial cells from the medium, their preservation by freeze-drying, and in blending of individual species or a combination thereof with the antibodies and the excipient of the product.